Profile picture of The Wall Street Journal
23andMe’s Fall From $6 Billion to Nearly $0: From celebrity “spit parties” to a drop in the bucket: The once-hot DNA-testing company is struggling to profit.
wsj.com/health/healthcare/23andme-anne-wojcicki-healthcare-stock-913468f4
23andMe’s Fall From $6 Billion to Nearly $0
Profile picture of The Wall Street Journal
23andMe Hack Is a Wake-Up Call for Your Password Habits: The incident at the DNA test-kit company highlights the risks of reused passwords.
wsj.com/tech/personal-tech/23andme-breach-hack-passwords-7587015f
23andMe Hack Is a Wake-Up Call for Your Password Habits
Profile picture of Bloomberg
23andMe Is Bringing DNA Sequencing for Health Risks To Consumers: Gene-testing company is transitioning into a health-care company.
bloomberg.com/news/articles/2023-10-25/23andme-is-bringing-dna-sequencing-for-health-risks-to-consumers
23andMe Is Bringing DNA Sequencing for Health Risks To Consumers
Profile picture of The Washington Post
Genetic tester 23andMe’s hacked data on Jewish users offered for sale online: A hacker is offering stolen information on millions of 23andMe users ...
washingtonpost.com/technology/2023/10/06/23andme-hacked-data/
Genetic tester 23andMe’s hacked data on Jewish users offered for sale ...
Profile picture of Barron's
Shake Shack Stock Blows Through the Roof. 23andMe Tumbles.: Shares of upscale burger chain Shake Shack have wiped out last year’s losses, while 23andMe stock set ...
barrons.com/articles/shake-shack-stock-23andme-d7f9abf4
Shake Shack Stock Blows Through the Roof. 23andMe Tumbles.
Profile picture of Fast Company
Why 23andMe CEO Anne Wojcicki says the medical world is at a “tipping point”: During the Fast Company Grill at SXSW, Anne Wojcicki explains why 23andMe is ...
fastcompany.com/90864819/why-23andme-ceo-anne-wojcicki-says-the-medical-world-is-at-a-tipping-point
Why 23andMe CEO Anne Wojcicki says the medical world is at a “tipping ...
Profile picture of Inc.com
Watch: 23andMe Co-Founder Is Shaking Up the Balance of Power in Healthcare: How Anne Wojcicki leveraged transparency and accessibility to build a successful ...
inc.com/nick-hawkins/this-founder-is-shaking-up-balance-of-power-in-healthcare.html
Watch: 23andMe Co-Founder Is Shaking Up the Balance of Power in Healthcare
Profile picture of Financial Times
Women twice as likely to suffer from long Covid, study suggests : People with a history of autoimmune disease or depression were also more likely to have the ...
ft.com/content/ea2d58c5-ae62-442c-b721-364c95852209
Women twice as likely to suffer from long Covid, study suggests
Profile picture of MarketWatch
Profile picture of Fast Company
Harvard study: Want to be less depressed? Wake up earlier: Researchers analyzed genetic data on 850,000 people through the company 23andMe ...
fastcompany.com/90642798/harvard-study-want-to-be-less-depressed-wake-up-earlier
Harvard study: Want to be less depressed? Wake up earlier
Profile picture of thedailybeast.com
At-Home Health Tests Are Booming Despite Lack of FDA Regulation: COVID flung open the doors to a new world of health tests that ship directly to consumers ...
thedailybeast.com/at-home-health-tests-are-booming-despite-lack-of-fda-regulation
At-Home Health Tests Are Booming Despite Lack of FDA Regulation
Profile picture of The Sacramento Bee
Why does COVID leave some without smell or taste? Study finds possible genetic clues
sacbee.com/news/coronavirus/article257491479.html
Why does COVID leave some without smell or taste? Study finds possible ...
Profile picture of Insider (news website)

Find out how genetic testing firms like 23andMe and Ancestry are aiming to disrupt the healthcare industry.

Key Players in Genetic Testing | Insider Intelligence: In the Key Players in Genetic Testing report, Insider Intelligence gives an overview of the four genetic ...
businessinsider.com/intelligence/key-players-in-genetic-testing
Key Players in Genetic Testing | Insider Intelligence
Profile picture of Barron's
23andMe Is a Biotech Masquerading As a Digital Health Firm, Analyst Says: The maker of at-home DNA test kits could become a powerful drug developer ...
barrons.com/articles/23andme-is-really-a-biotech-citi-says-51626108392
23andMe Is a Biotech Masquerading As a Digital Health Firm, Analyst Says
Profile picture of Forbes
6 Companies That Are Taking Telemedicine By Storm: The coronavirus pandemic turned much of our lives digital, and healthcare was no exception ...
forbes.com/sites/serenitygibbons/2021/04/22/6-companies-that-are-taking-telemedicine-by-storm/
6 Companies That Are Taking Telemedicine By Storm
Profile picture of Los Angeles Times
Why buy Ancestry's DNA data if you don't plan to use it?: Investment firm Blackstone acquired the genealogical site Ancestry for $4.7 billion ...
latimes.com/business/story/2021-04-13/column-blackstone-ancestry-genetic-privacy
Why buy Ancestry's DNA data if you don't plan to use it?
Profile picture of Insider (news website)
DNA testing company strategies: 23andMe, Color, Invitae, Helix: Genetic tests were once a popular trend. Now, companies like Color have set their sights on less ...
businessinsider.com/dna-test-company-pivot-strategies-23andme-color-invitae-helix-ancestry-2021-3
DNA testing company strategies: 23andMe, Color, Invitae, Helix
Profile picture of The New York Times
The Sunday Read: ‘Sigrid Johnson Was Black. A DNA Test Said She Wasn’t’: The surge in popularity of services like 23andMe and Ancestry means that more and more ...
nytimes.com/2021/02/28/podcasts/the-daily/genetics-dna-tests-ancestry.html
The Sunday Read: ‘Sigrid Johnson Was Black. A DNA Test Said She Wasn’t’
Profile picture of Insider (news website)
How Apple, Google, 23andMe, and other companies are fighting COVID-19: These eight tech companies are creating solutions to fight COVID-19, from Apple and ...
businessinsider.com/how-apple-google-23andme-and-others-are-fighting-covid-19-2020-5
How Apple, Google, 23andMe, and other companies are fighting COVID-19
Profile picture of Insider (news website)
23andMe cofounder Anne Wojcicki interview on decision to do a SPAC IPO: 23andMe is going public via a merger with Richard Branson's SPAC. The deal could value ...
businessinsider.com/23andme-cofounder-anne-wojcicki-interview-explains-decision-spac-ipo-2021-2
23andMe cofounder Anne Wojcicki interview on decision to do a SPAC IPO
Profile picture of Fortune (magazine)
Calculate how at risk you could be for a severe case of COVID with this new tool: DNA-testing company 23andMe Inc. has launched a new COVID-19 Severity ...
fortune.com/2021/01/27/covid-symptoms-cases-severity-risk-calculator-23andme-study-results-coronavirus-news/
Calculate how at risk you could be for a severe case of COVID with this ...
Profile picture of Fortune (magazine)
DNA tester 23andMe to go public at $3.5 billion through Branson-backed SPAC: Consumer DNA-testing company 23andMe plans to merge with VG Acquisition Corp. ...
fortune.com/2021/02/04/23andme-going-public-spac-richard-branson-valuation-dna-testing/
DNA tester 23andMe to go public at $3.5 billion through Branson-backed ...
Profile picture of Insider (news website)
23andMe cofounder Anne Wojcicki interview on decision to do a SPAC IPO: 23andMe is going public via a merger with Richard Branson's SPAC. The deal could value ...
businessinsider.com/23andme-cofounder-anne-wojcicki-interview-explains-decision-spac-ipo-2021-2
23andMe cofounder Anne Wojcicki interview on decision to do a SPAC IPO
Profile picture of Insider (news website)
Digital health salaries revealed: What 23andMe, Verily, and more pay - Business Insider
businessinsider.com/digital-health-salaries-revealed-what-23andme-verily-and-more-pay-2020-11
Digital health salaries revealed: What 23andMe, Verily, and more pay - ...
Profile picture of The Washington Post
Pandemic sparks more people to hunt for their birthparents, long lost relatives: Finding a father, a mother or other kin becomes a bigger goal for some ...
washingtonpost.com/health/covid-search-for-birthparents/2020/09/18/def0a132-e7c9-11ea-97e0-94d2e46e759b_story.html
Pandemic sparks more people to hunt for their birthparents ...
Profile picture of The Washington Post

Experts, including former CDC director Tom Frieden, MD, and 23andMe CEO Anne Wojcicki, join The Post to discuss what has been learned during the coronavirus ...